Stockscreener 앱 받기
14.93
0.27%
-0.04
시간 외 거래:
14.85
-0.08
-0.54%
전일 마감가:
$14.97
열려 있는:
$14.91
하루 거래량:
223.43K
Relative Volume:
0.38
시가총액:
$961.46M
수익:
-
순이익/손실:
-
주가수익비율:
-14.84
EPS:
-1.0062
순현금흐름:
-
1주 성능:
+22.68%
1개월 성능:
+82.52%
6개월 성능:
+929.66%
1년 성능:
+637.28%
1일 변동 폭
$14.68
$15.33
1주일 범위
$12.07
$15.93
52주 변동 폭
$0.8786
$17.25
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
Compare ANL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
14.93 | 964.04M | 0 | 0 | 0 | -1.0062 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-20 | 개시 | Leerink Partners | Outperform |
| 2026-02-13 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-06-02 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-09-04 | 개시 | H.C. Wainwright | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Adlai Nortye (NASDAQ:ANL) Trading 12.3% HigherHere's Why - MarketBeat
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Is Adlai (ANL) stock a strong investment pick (Volatility Increases) 2026-04-27Earnings Miss Stocks - Newser
Adlai Nortye (NASDAQ: ANL) registers $600M shelf; 32.9M ADS resale - Stock Titan
Adlai Nortye (NASDAQ:ANL) Shares Gap DownTime to Sell? - MarketBeat
Adlai Nortye FY2026 EPS Forecast Raised by HC Wainwright - MarketBeat
Adlai Nortye (NASDAQ:ANL) Sets New 1-Year HighStill a Buy? - MarketBeat
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright - TipRanks
Adlai (ANL) Stock Rallies on Launch (Smart Money Exits) 2026-04-20Fast Rising Stocks - Newser
Adlai Nortye (NASDAQ:ANL) Stock Price Up 18.1%What's Next? - MarketBeat
Adlai Nortye raises $150M in oversubscribed private placement By Investing.com - Investing.com India
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing - Sahm
Adlai Nortye Raises $150 Million in Oversubscribed Private Placement to Advance Cancer Pipeline - TipRanks
Adlai Nortye (NASDAQ:ANL) Shares Gap UpShould You Buy? - MarketBeat
Adlai Nortye raises $150M in oversubscribed private placement - Investing.com
TeraWulf, BRP And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Adlai Nortye (NASDAQ:ANL) Trading Down 11.7%Here's What Happened - MarketBeat
Adlai Nortye (NASDAQ:ANL) Reaches New 52-Week HighShould You Buy? - MarketBeat
Day's Trending USA Stocks | AVNS: Overnight gain 69.5%, Surges on All-Cash Acquisition Deal by American Industrial Partners - Sahm
Adlai Nortye (ANL) Loss Narrows To US$18.3 Million Challenging Bearish Cash Burn Narrative - Sahm
FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - qz.com
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up - The Globe and Mail
Is Adlai Nortye Ltd. sponsored ADR (ANL) outperforming other medical stocks this year? - MSN
Adlai Nortye Ltd. sponsored ADR (ANL) upgraded to buy: Here's why - MSN
Adlai Nortye Ltd. Sponsored ADR (ANL) Raised to Buy: The Reason Behind This Change - Bitget
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why - Yahoo Finance
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and Ollie’s Bargain Outlet Holding (OLLI) - The Globe and Mail
Adlai Nortye (NASDAQ: ANL) files $600M shelf; 21.5M ADSs resale - Stock Titan
Is Adlai Nortye Ltd. Sponsored ADR (ANL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and Compass Therapeutics (CMPX) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Ionis Pharmaceuticals (IONS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Integer Holdings (ITGR) and Tonix Pharma (TNXP) - The Globe and Mail
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Adlai Nortye upgraded to Buy at H.C. Wainwright as AN9025 enters clinic - TipRanks
H.C. Wainwright upgrades Adlai Nortye stock rating to Buy with $16 target - Investing.com South Africa
Adlai Nortye Doses First Patient in Global Phase 1 Trial of Pan-RAS Inhibitor AN9025 - TipRanks
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations - GlobeNewswire Inc.
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Rises By 458.7% - MarketBeat
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline - The Globe and Mail
Adlai Nortye raises $140 million in private placement By Investing.com - Investing.com South Africa
Adlai Nortye prices 64.6M shares at $2.17 in private placement - TipRanks
Adlai Nortye raises $140 million in private placement - Investing.com
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Decrease in Short Interest - Defense World
AIFU Inc. – Sponsored ADR (NASDAQ:AIFU) Short Interest Update - Defense World
Adlai Nortye Ltd Adr (ANL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):